TY - JOUR
T1 - Questionnaire- and linkage-based outcomes in Dutch childhood cancer survivors
T2 - Methodology of the DCCSS LATER study part 1
AU - DCCSS LATER Study Group
AU - Teepen, Jop C
AU - Kok, Judith L
AU - Feijen, Elizabeth A M
AU - Loonen, Jacqueline J
AU - van den Heuvel-Eibrink, Marry M
AU - van der Pal, Helena J
AU - Tissing, Wim J E
AU - Bresters, Dorine
AU - Versluys, Birgitta
AU - Grootenhuis, Martha A
AU - Louwerens, Marloes
AU - Neggers, Sebastian J C M M
AU - van Santen, Hanneke M
AU - de Vries, Andrica
AU - Janssens, Geert O
AU - den Hartogh, Jaap G
AU - van Leeuwen, Flora E
AU - Hollema, Nynke
AU - Streefkerk, Nina
AU - Kilsdonk, Ellen
AU - van der Heiden-van der Loo, Margriet
AU - van Dulmen-den Broeder, Eline
AU - Ronckers, Cécile M
AU - Kremer, Leontien C M
N1 - © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
PY - 2023
Y1 - 2023
N2 - BACKGROUND: Childhood cancer survivors are at risk for developing long-term adverse health outcomes. To identify the risk of and risk factors for specific health outcomes, well-established cohorts are needed with detailed information on childhood cancer diagnosis, treatment, and health outcomes. We describe the design, methodology, characteristics, and data availability of the Dutch Childhood Cancer Survivor Study LATER cohort (1963-2001) part 1; questionnaire and linkage studies.METHODS: The LATER cohort includes 5-year childhood cancer survivors, diagnosed in the period 1963-2001, and before the age of 18 in any of the seven former pediatric oncology centers in the Netherlands. Information on health outcomes from survivors and invited siblings of survivors was collected by questionnaires and linkages to medical registries.RESULTS: In total, 6165 survivors were included in the LATER cohort. Extensive data on diagnosis and treatment have been collected. Information on a variety of health outcomes has been ascertained by the LATER questionnaire study and linkages with several registries for subsequent tumors, health care use, and hospitalizations.CONCLUSION: Research with data of the LATER cohort will provide new insights into risks of and risk factors for long-term health outcomes. This can enhance risk stratification for childhood cancer survivors and inform surveillance guidelines and development of interventions to prevent (the impact of) long-term adverse health outcomes. The data collected will be a solid baseline foundation for future follow-up studies.
AB - BACKGROUND: Childhood cancer survivors are at risk for developing long-term adverse health outcomes. To identify the risk of and risk factors for specific health outcomes, well-established cohorts are needed with detailed information on childhood cancer diagnosis, treatment, and health outcomes. We describe the design, methodology, characteristics, and data availability of the Dutch Childhood Cancer Survivor Study LATER cohort (1963-2001) part 1; questionnaire and linkage studies.METHODS: The LATER cohort includes 5-year childhood cancer survivors, diagnosed in the period 1963-2001, and before the age of 18 in any of the seven former pediatric oncology centers in the Netherlands. Information on health outcomes from survivors and invited siblings of survivors was collected by questionnaires and linkages to medical registries.RESULTS: In total, 6165 survivors were included in the LATER cohort. Extensive data on diagnosis and treatment have been collected. Information on a variety of health outcomes has been ascertained by the LATER questionnaire study and linkages with several registries for subsequent tumors, health care use, and hospitalizations.CONCLUSION: Research with data of the LATER cohort will provide new insights into risks of and risk factors for long-term health outcomes. This can enhance risk stratification for childhood cancer survivors and inform surveillance guidelines and development of interventions to prevent (the impact of) long-term adverse health outcomes. The data collected will be a solid baseline foundation for future follow-up studies.
KW - Child
KW - Humans
KW - Neoplasms/epidemiology
KW - Cancer Survivors
KW - Follow-Up Studies
KW - Survivors
KW - Surveys and Questionnaires
U2 - 10.1002/cam4.5519
DO - 10.1002/cam4.5519
M3 - Article
C2 - 36519590
SN - 2045-7634
VL - 12
SP - 7588
EP - 7602
JO - Cancer Medicine
JF - Cancer Medicine
IS - 6
ER -